IVSS Fees and Costs — Applied Finance IVS US SMID ETF

Data updated: 2026-08-25

The net expense ratio is 59.00%. There are no sales loads or redemption fees. Portfolio turnover was 0%.

IVSS Fees and Expenses

Annual operating expenses and sales charges of IVSS. Prospectus, as of April 30, 2026.

Annual operating expenses
Management fee59.00%
12b-1 fee0.00%
Other expenses0.00%
Gross expense ratio59.00%
Fee waiver—
Net expense ratio59.00%
Sales charges
Max front load—
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)No
Fees waived or reduced during the yearNo
Waived fees subject to recoupmentNo

IVSS Costs Over Time

On $10,000 invested in IVSS, assuming 5% a year before costs, total costs come to $12,615 over 5 years, cutting the return by 61.95% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 59.00%)$6,195$10,010$10,717
Lost growth on money paid in costs$0$768$1,898
Total costs$6,195$10,778$12,615
Value after costs$4,305$798$148
Impact on return, per year61.95%61.95%61.95%

IVSS Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending December 31, 2025.

  • Explicit cost rate (commissions ÷ average net assets): —
  • Total broker commissions: —
  • Bought from dealers (principal trades, not a cost): $5.7M
  • Portfolio turnover (prospectus): 0%
  • Securities lending: none during the year

IVSS Dealer Counterparties

Securities bought directly from dealers (principal trades).

BrokerAmountShare
Goldman Sachs & Co. LLC$5.7M100.00%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.